What We're Reading: Page 3
Industry reads hand-picked by our editors
Nov 21, 2025
-
The Atlantic
RFK Jr.’s Miasma Theory of Health Is Spreading
-
CNBC
Health care leaders’ letter to the FDA: Concerns about approvals for rare disease therapeutics
-
Bloomberg
Ozempic Users Win Eye-Disease Compensation in Novo’s Home Market
-
Reuters
Republican-led states challenge FDA approval of new generic abortion pill
Nov 20, 2025
-
The Washington Post
CDC promotes false vaccines-autism link in stunning shift under RFK Jr.
-
The Wall Street Journal
Millions of Kids Are on ADHD Pills. For Many, It’s the Start of a Drug Cascade.
-
Politico
RFK Jr. is in a power struggle
-
Scientific American
Personalized mRNA Vaccines Will Revolutionize Cancer Treatment—If Federal Funding Cuts Don’t Doom Them
Nov 19, 2025
Nov 18, 2025
-
The Washington Post
Trump slashed spending on clinical trials. The toll is starting to become clear.
-
BioCentury
Kennedy, Makary vows to avoid political interference at CDER will be tested soon
-
ProPublica
What the U.S. Government Is Dismissing That Could Seed a Bird Flu Pandemic
-
Bloomberg Law
Supreme Court Rejects Review of FDA Denial of Vanda Stomach Drug
Nov 17, 2025
-
The Washington Post
First, the frogs died. Then people got sick.
-
The Wall Street Journal
RFK Jr. Discussed Curbing FDA Head’s Role After Complaints About Management Style
-
The New York Times
Frustrated by the Medical System, Patients Turn to A.I.
-
CNN
Novo Nordisk further lowers prices for weight loss, diabetes drugs for those who pay cash
Previous
